Drug Shortage Report for REVATIO

Last updated on 2018-10-10
Report ID 63649
Drug Identification Number 02341611
Brand name REVATIO
Common or Proper name REVATIO
Company Name PFIZER CANADA ULC
Active Ingredient(s) SILDENAFIL
Strength(s) 0.8MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1x 12.5ML VIAL
ATC code C02
ATC description OTHER ANTIHYPERTENSIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-10-09
Estimated end date 2018-12-12
Actual end date
Shortage status Actual shortage
Updated date 2018-10-10
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com